Corporate Banner
Satellite Banner
Technology Networks Header
Friday, October 31, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
CHN Analyzer for Contract Research Organizations and Service Labs
Friday, February 14, 2014
Model 440 delivers simultaneous CHN analysis in less than 5 minutes.

Biotage Announces the Launch of ISOLUTE® PLD+
Monday, January 27, 2014
Improved sensitivity with the new protein and phospholipid removal plate.

Powerful Evaporator for Drug Discovery
Thursday, January 02, 2014
The HT-4X centrifugal evaporator from Genevac provides optimised sample preparation capabilities for scientists working in the drug discovery environment.

Powerful Evaporator for Drug Discovery
Thursday, December 19, 2013
HT-4X centrifugal evaporator combines ease of use, compactness and operational versatility.

Vapourtec Keeps it Cool with Patented Cooled Reactor System
Tuesday, December 03, 2013
The patented Cooled Reactor system, developed by Vapourtec and launched in 2010, is continuing to play a key role in major flow chemistry research breakthroughs.

Mettler-Toledo Presents Live Webinar on Ensuring USP Compliance
Friday, November 29, 2013
Mr. Gregory Martin will explain the implications of the latest USP revisions for balance users.

Easily Determine Trace Morpholine and More in Linezolid
Tuesday, November 26, 2013
Determination of morpholine in linezolid by ion chromatography method.

Huber RotaCool® Chiller Now Reduced in Price
Friday, November 15, 2013
Highest cooling capacity at minimal bench space - now for 20 percent less!

Rapidly Explore Available Chemistry Space in Spark V10.2
Friday, November 15, 2013
Powerful tool for finding biologically equivalent replacements for key moieties in users molecule.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 1275
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv